Among the many parasitic diseases observed in the
tropics, Toxoplasmosis is a fairly common occurrence. An infected pregnant
woman can transmit it, transplacentally, to
her foetus. Two cases of congenital toxoplasmosis are discussed in this study. One patient is at 7 days of
life, while the other is at 9 days of life. The newborns displayed the
typical symptoms of jaundice, hepatosplenomegaly, chorioretinitis, and
cranioencephalic abnormalities. However, the uniqueness of these observations
is the presence of umbilical haemorrhage, asymptom not described in the
literature researched. The evolution of this
finding, during treatment is distinguished by the symptoms persisting until six months of age, in addition to growth retardation of
saturation-weight, with no retardation of psychomotor development in one
patient, and with hydrocephalus accompanied by psychomotor retardation in the
other one. Hence, it is recommended that
pregnant women are systematically screened for toxoplasmosis, and
seronegative women are monitored; in fact, the early and suitable management of
congenital toxoplasmosis will significantly control this parasitosis.
References
[1]
Wolf, A., Cowen, D. and Paige, B. (1939) Human Toxoplasmosis: Occurrence in Infants as an Encephalomyelitis Verification by Transmission to Animals. Science, 89, 226-227. https://doi.org/10.1126/science.89.2306.226
[2]
Saghrouni, F., Khammari, I., Ben Abdeljelil, J., Yaacoub, A., Gaïed, S., Meksi, A., et al. (2013) La toxoplasmose congénitale: A propos de 21 cas. Journal de Pédiatrie et de Puériculture, 26, 83-89. https://doi.org/10.1016/j.jpp.2013.01.004
[3]
Bagnan-Tossa, L., D’Almeida, M., Bello, D., Alihonou, F. and Ayivi, B. (2014) La toxoplasmose congénitale forme multiviscérale: A propos d’un cas. Archives de Pédiatrie, 21, 806. https://doi.org/10.1016/S0929-693X(14)72066-4
[4]
Yugbaré-Ouédraogo, S.O., Sawadogo, H., Toguyeni-Tamini, L., Dao, L., Nagalo, K. and Yé-Ouattara, D. (2018) Toxoplasmose congénitale: A propos d’un cas sévère au CHU pédiatrique Charles de Gaulle de Ouagadougou (Burkina Faso). Journal Africain de Pédiatrie et de Génétique Médicale, 5, 58-61.
[5]
Flores, C., Villalobos-Cerrud, D., Borace, J., Fábrega, L., Norero, X., Sáez-Llorens, X., et al. (2021) Epidemiological Aspects of Maternal and Congenital Toxoplasmosis in Panama. Pathogens, 10, 764. https://doi.org/10.3390/pathogens10060764
[6]
Torgerson, P.R. and Mastroiacovo, P. (2013) The Global Burden of Congenital Toxoplasmosis: A Systematic Review. Bulletin of the World Health Organization, 91, 501-508. https://doi.org/10.2471/BLT.12.111732
[7]
Bamba, S., Some, D.A., Chemla, C., Geers, R., Guiguemde, T.R. and Villena, I. (2012) Analyse sérologique de la toxoplasmose pergravidique: Evaluation des risques et perspectives du dépistage prénatal au centre hospitalier universitaire de Bobo-Dioulasso au Burkina Faso. The Pan African Medical Journal, 12, 43.
[8]
Bamba, S., Cissé, M., Sangaré, I., Zida, A., Ouattara, S. and Guiguemdé, R.T. (2017) Seroprevalence and Risk Factors of Toxoplasma gondii Infection in Pregnant Women from Bobo-Dioulasso, Burkina Faso. BMC Infectious Diseases, 17, 482.
https://doi.org/10.1186/s12879-017-2583-6
[9]
Beazley, D. and Egerman, R.S. (1998) Toxoplasmosis. Seminars in Perinatology, 22, 332-338. https://doi.org/10.1016/S0146-0005(98)80022-0
[10]
Remington, J.S., McLeod, R., Thulliez, P. and Desmonts, G. (2001) Toxoplasmosis. In: Remington, J.S., Klein, J.O., Baker, C.B. and Wilson, C.J., Eds., Infectious Diseases of the Fetus and Newborn Infant, 5th Edition, WB Saunders, Philadelphia, 205-346.
[11]
Martin, S. (2001) Congenital Toxoplasmosis. Neonatal Network, 20, 23-30.
https://doi.org/10.1891/0730-0832.20.4.23
[12]
Villena, I., Ancelle, T., Delmas, C., Garcia, P., Brezin, A.P., Thulliez, P., et al. (2010) Congenital Toxoplasmosis in France in 2007: First Results from a National Surveillance System. Eurosurveillance, 15, 19600.
https://doi.org/10.2807/ese.15.25.19600-en
[13]
Ly, F. (2016) Toxoplasmose congénitale dans sa forme infraclinique à révélation tardive. Revue du CAMES: Science de la Santé, 4, 58-61.
[14]
Abdellaoui, T., Laaribi, N., Ajhoun, Y., Zerrouk, R., Elasri, F., Reda, K., et al. (2017) Grande cicatrice maculaire de toxoplasmose congénitale. Journal Français d’Ophtalmologie, 41, 93. https://doi.org/10.1016/j.jfo.2017.04.018
[15]
Tiama, J.M.L., Konipo, A., Dakouo, P., Coulibaly, T. and Dena, T. (2020) Choriorétinite cicatricielle bilatérale chez une fille de 05 ans: Séquelles de toxoplasmose congénitale? Revue Malienne d’Infectiologie et de Microbiologie, 15, 8-10. https://doi.org/10.53597/remim.v15i2.1724
[16]
Oz, H.S. (2017) Fetomaternal and Pediatric Toxoplasmosis. Journal of Pediatric Infectious Diseases, 12, 202-208. https://doi.org/10.1055/s-0037-1603942
[17]
Dardé, M.L. and Peyron, F. (2014) Toxoplasme et toxoplasmose. Journal de Pédiatrie et de Puériculture, 27, 294-308. https://doi.org/10.1016/j.jpp.2014.10.003
[18]
Peyron, F., L’ollivier, C., Mandelbrot, L., Wallon, M., Piarroux, R., Kieffer, F., et al. (2019) Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens, 8, 24.
https://doi.org/10.3390/pathogens8010024
[19]
Robert-Gangneux, F. and Dion, S. (2020) Toxoplasmose de la femme enceinte. Journal de Pédiatrie et de Puériculture, 33, 209-220.
https://doi.org/10.1016/j.jpp.2020.04.005
[20]
McLeod, R., Boyer, K., Karrison, T., Kasza, K., Swisher, C., Roizen, N., et al. (2006) Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clinical Infectious Diseases, 42, 1383-1394. https://doi.org/10.1086/501360
[21]
Dunn, D., Wallon, M., Peyron, F., Petersen, E., Peckham, C. and Gilbert, R. (1999) Mother-to-Child Transmission of Toxoplasmosis: Risk Estimates for Clinical Counselling. The Lancet, 353, 1829-1833.
https://doi.org/10.1016/S0140-6736(98)08220-8
[22]
Cotty, F., Carpentier, M.A. and Descamps, P. (1997) Toxoplasmose congénitale avec hydrocéphalie diagnostiquée in utero: Evolution sous traitement. Archives de Pédiatrie, 4, 247-250. https://doi.org/10.1016/S0929-693X(97)87240-5
[23]
Peyron, F., Garweg, J.G., Wallon, M., Descloux, E., Rolland, M. and Barth, J. (2011) Long-Term Impact of Treated Visual Congenital Toxoplasmosis on Quality of Life and Performance. The Pediatric Infectious Disease Journal, 30, 597-600.
https://doi.org/10.1097/INF.0b013e31820bb5f3
[24]
Wallon, M., Garweg, J.G., Abrahamowicz, M., Cornu, C., Vinault, S., Quantin, C., et al. (2014) Ophthalmic Outcomes of Congenital Toxoplasmosis Followed until Adolescence. The Journal of Pediatrics, 133, e601-e608.
https://doi.org/10.1542/peds.2013-2153
[25]
Hoekstra, F., Buzing, C., Sporken, J.M.J., Erasmus, C.E., van der Flier, M. and Semmekrot, B.A. (2011) [Congenital Toxoplasmosis: Severe Ocular and Neurological Complications]. Nederlands Tijdschrift voor Geneeskunde, 155, A2853.
[26]
Roizen, N., Swisher, C.N., Stein, M.A., Hopkins, J., Boyer, K.M., Holfels, E., et al. (1995) Neurologic and Developmental Congenital Outcome in Treated Toxoplasmosis. The Journal of Pediatrics, 95, 11-20.
